• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist


37.6000 USD 0.9200 2.51%

As of 20:10:00 ET on 10/22/2014.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 36.8300 Day's Range: 36.4900 - 38.4200 Volume: 1,083,374
Previous Close: 36.6800 52wk Range: 20.0200 - 42.5000 1-Yr Rtn: +48.09%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 37.6000
  • 1D
  • 1M
  • 1Y
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 16.3478
Estimated P/E(06/2015) 19.8837
Relative P/E vs. SPX 0.9479
Earnings Per Share (USD) (ttm) 2.3000
Est. EPS (USD) (06/2015) 1.8910
Est. PEG Ratio 1.2842
Market Cap (M USD) 2,744.72
Shares Outstanding (M) 73.00
30 Day Average Volume 772,249
Price/Book (mrq) 3.8435
Price/Sale (ttm) 3.6583
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderRobert Gardner HarrisonChief Information Officer
R Bryan RiggsbeeExec VP/CFO/TreasurerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil